OBJECTIVE: The authors sought to determine whether caudate nucleus volumes or specific genotypes predict psychomotor slowing in older persons with depression. METHOD: Forty-seven persons with depression (mean age=51.8 years, SD=12.4) and 20 healthy volunteers (mean age=56.1 years, SD=9.8) underwent clinical assessments, a neuropsychological test of psychomotor speed (part A of the Trail Making Test), high-resolution magnetic resonance imaging scans, and genotyping for the apolipoprotein E epsilon4 allele and a mutation of the methylenetetrahydrofolate reductase enzyme. RESULTS: Multivariate analyses revealed that psychomotor speed was uniquely predicted by age, a diagnosis of depression, right caudate nucleus volume, and mutation of the methylenetetrahydrofolate reductase enzyme. CONCLUSIONS: Psychomotor slowing, a key clinical and cognitive phenomenon in older persons with depression, is predicted by reduced caudate nucleus volumes and genetic determinants of homocysteine metabolism.
OBJECTIVE: The authors sought to determine whether caudate nucleus volumes or specific genotypes predict psychomotor slowing in older persons with depression. METHOD: Forty-seven persons with depression (mean age=51.8 years, SD=12.4) and 20 healthy volunteers (mean age=56.1 years, SD=9.8) underwent clinical assessments, a neuropsychological test of psychomotor speed (part A of the Trail Making Test), high-resolution magnetic resonance imaging scans, and genotyping for the apolipoprotein E epsilon4 allele and a mutation of the methylenetetrahydrofolate reductase enzyme. RESULTS: Multivariate analyses revealed that psychomotor speed was uniquely predicted by age, a diagnosis of depression, right caudate nucleus volume, and mutation of the methylenetetrahydrofolate reductase enzyme. CONCLUSIONS:Psychomotor slowing, a key clinical and cognitive phenomenon in older persons with depression, is predicted by reduced caudate nucleus volumes and genetic determinants of homocysteine metabolism.
Authors: Jeylan S Buyukdura; Shawn M McClintock; Paul E Croarkin Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2010-10-31 Impact factor: 5.067
Authors: Meryl A Butters; Howard J Aizenstein; Kiralee M Hayashi; Carolyn C Meltzer; Jamie Seaman; Charles F Reynolds; Arthur W Toga; Paul M Thompson; James T Becker Journal: Am J Geriatr Psychiatry Date: 2009-01 Impact factor: 4.105
Authors: Rajesh Kumar; Mary A Woo; Paul M Macey; Gregg C Fonarow; Michele A Hamilton; Ronald M Harper Journal: J Neurol Sci Date: 2011-05-25 Impact factor: 3.181
Authors: Chih-Chuan Pan; Douglas R McQuoid; Warren D Taylor; Martha E Payne; Allison Ashley-Koch; David C Steffens Journal: Int J Geriatr Psychiatry Date: 2009-08 Impact factor: 3.485
Authors: P Cédric M P Koolschijn; Neeltje E M van Haren; Gerty J L M Lensvelt-Mulders; Hilleke E Hulshoff Pol; René S Kahn Journal: Hum Brain Mapp Date: 2009-11 Impact factor: 5.038